Public-registry site landscape for NCT06433999, a Dermatomyositis study sponsored by Priovant Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06433999 (registry record) |
| Sponsor | Priovant Therapeutics, Inc. |
| Condition(s) | Dermatomyositis; Dermatomyositis, Adult Type |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT06433999 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →